THOUSAND
OAKS, Calif., May 30, 2025
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies
Global Healthcare Conference at 9:20 a.m. ET
on Wednesday, June 4, 2025. Peter
Griffith, executive vice president and chief financial
officer at Amgen, and Murdo Gordon,
executive vice president of Global Commercial Operations at Amgen,
will present at the conference. The webcast will be broadcast over
the internet simultaneously and will be available to members of the
news media, investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at
certain investor and medical conferences, can be found
on Amgen's website, www.amgen.com, under Investors.
Information regarding presentation times, webcast availability and
webcast links are noted on Amgen's Investor Relations Events
Calendar. The webcast will be archived and available for replay for
at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers
innovative medicines to help millions of patients in their fight
against some of the world's toughest diseases. More than 40 years
ago, Amgen helped to establish the biotechnology industry
and remains on the cutting-edge of innovation, using technology and
human genetic data to push beyond what's known
today. Amgen is advancing a broad and deep pipeline that
builds on its existing portfolio of medicines to treat cancer,
heart disease, osteoporosis, inflammatory diseases and rare
diseases.
In 2024, Amgen was named one of the "World's Most
Innovative Companies" by Fast Company and one of
"America's Best Large Employers" by Forbes, among
other external recognitions. Amgen is one of the 30
companies that comprise the Dow Jones Industrial Average®, and it
is also part of the Nasdaq-100 Index®, which includes the largest
and most innovative non-financial companies listed on
the Nasdaq Stock Market based on market
capitalization.
For more information, visit Amgen.com and follow us
on X (formerly known as Twitter), LinkedIn, Instagram,
YouTube and Threads.
CONTACT: Amgen, Thousand
Oaks
Elissa Snook, 609-251-1407
(media)
Justin Claeys, 805-313-9775
(investors)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-jefferies-global-healthcare-conference-302469548.html
SOURCE Amgen
